Back to School: How biopharma can reboot drug development. Access exclusive analysis here

QLT misses Street EPS

QLT (QLTI; TSE:QLT) reported second quarter EPS of C$0.09 (US$0.06), missing the consensus estimate by

Read the full 157 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE